Clinical trials
Phase 2/3 COVID-19 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 34 |
| 2021 | 21 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 27 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioNTech SE | 4 |
| Pfizer | 4 |
| ModernaTX, Inc. | 3 |
| Novavax | 3 |
| Cellular Sciences, inc. | 2 |
| Gilead Sciences | 2 |
| Merck Sharp & Dohme LLC | 2 |
| RedHill Biopharma Limited | 2 |
| University of Washington | 2 |
| APR Applied Pharma Research s.a. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 67 |
| Coronavirus Infections | 18 |
| Virus Diseases | 5 |
| Severe Acute Respiratory Syndrome | 4 |
| Inflammation | 3 |
| Pneumonia | 3 |
| Respiratory Distress Syndrome | 3 |
| Acute Lung Injury | 2 |
| Cytokine Release Syndrome | 2 |
| Post-Acute COVID-19 Syndrome | 2 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.